JP2010502715A5 - - Google Patents

Download PDF

Info

Publication number
JP2010502715A5
JP2010502715A5 JP2009527430A JP2009527430A JP2010502715A5 JP 2010502715 A5 JP2010502715 A5 JP 2010502715A5 JP 2009527430 A JP2009527430 A JP 2009527430A JP 2009527430 A JP2009527430 A JP 2009527430A JP 2010502715 A5 JP2010502715 A5 JP 2010502715A5
Authority
JP
Japan
Prior art keywords
substituted
butanol
tert
pharmaceutically acceptable
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009527430A
Other languages
English (en)
Japanese (ja)
Other versions
JP5955494B2 (ja
JP2010502715A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/019561 external-priority patent/WO2008030570A1/en
Publication of JP2010502715A publication Critical patent/JP2010502715A/ja
Publication of JP2010502715A5 publication Critical patent/JP2010502715A5/ja
Application granted granted Critical
Publication of JP5955494B2 publication Critical patent/JP5955494B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009527430A 2006-09-08 2007-09-06 1,2,4−オキサジアゾール安息香酸の製造方法 Active JP5955494B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US84359506P 2006-09-08 2006-09-08
US60/843,595 2006-09-08
PCT/US2007/019561 WO2008030570A1 (en) 2006-09-08 2007-09-06 Processes for the preparation of 1,2,4-oxadiazole benzoic acids

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014103966A Division JP2014193896A (ja) 2006-09-08 2014-05-20 1,2,4−オキサジアゾール安息香酸の製造方法

Publications (3)

Publication Number Publication Date
JP2010502715A JP2010502715A (ja) 2010-01-28
JP2010502715A5 true JP2010502715A5 (https=) 2010-10-21
JP5955494B2 JP5955494B2 (ja) 2016-07-20

Family

ID=38935880

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2009527430A Active JP5955494B2 (ja) 2006-09-08 2007-09-06 1,2,4−オキサジアゾール安息香酸の製造方法
JP2014103966A Pending JP2014193896A (ja) 2006-09-08 2014-05-20 1,2,4−オキサジアゾール安息香酸の製造方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014103966A Pending JP2014193896A (ja) 2006-09-08 2014-05-20 1,2,4−オキサジアゾール安息香酸の製造方法

Country Status (24)

Country Link
US (2) US7678922B2 (https=)
EP (1) EP2059513B1 (https=)
JP (2) JP5955494B2 (https=)
KR (1) KR101466368B1 (https=)
CN (1) CN101535284B (https=)
AR (3) AR062715A1 (https=)
AU (1) AU2007292915B2 (https=)
BR (1) BRPI0716996B8 (https=)
CA (2) CA2842625C (https=)
CL (1) CL2007002606A1 (https=)
DK (1) DK2059513T3 (https=)
ES (1) ES2404348T3 (https=)
IL (1) IL197445A (https=)
MX (1) MX2009002439A (https=)
MY (1) MY148598A (https=)
NZ (2) NZ598012A (https=)
PE (2) PE20080771A1 (https=)
PL (1) PL2059513T3 (https=)
PT (1) PT2059513E (https=)
RU (1) RU2495030C2 (https=)
TW (1) TWI482761B (https=)
UA (1) UA99265C2 (https=)
WO (1) WO2008030570A1 (https=)
ZA (1) ZA200901782B (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE047569T2 (hu) 2003-04-11 2020-04-28 Ptc Therapeutics Inc 1,2,4-oxadiazol-benzoesav vegyület és nonszensz szupresszióra történõ alkalmazása
PT2402002T (pt) 2005-04-08 2018-10-08 Ptc Therapeutics Inc Composições de 1,2,4-oxadiazole oralmente activo para terapia de supressão de mutações nonsense
RU2462246C2 (ru) 2006-03-30 2012-09-27 ПиТиСи ТЕРАПЬЮТИКС, ИНК. Способы получения функционального белка из днк, имеющей нонсенс-мутацию, и лечения нарушений, ассоциированных с ней
MX2009002439A (es) * 2006-09-08 2009-03-27 Ptc Therapeutics Inc Procesos para la preparacion de acidos 1,2,4-oxadiazolbenzoicos.
PL2076501T3 (pl) * 2006-09-25 2016-06-30 Ptc Therapeutics Inc Postacie krystaliczne kwasu 3-[5-(2-fluorofenylo)[1,2,4]oksadiazol-3-ilo]-benzoesowego
US8101641B2 (en) 2006-09-25 2012-01-24 Ptc Therapeutics, Inc. Hydroxylated 1,2,4-oxadiazole benzoic acid compounds and compositions thereof
RS54025B1 (sr) 2006-10-12 2015-10-30 Ptc Therapeutics Inc. Postupci doziranja oralno aktivnog 1,2,4-oksadiazola za supresionu terapiju nonsens mutacije
CN101714009A (zh) * 2009-05-14 2010-05-26 翁印嵩 集成通用电话功能的计算机
EP2668951B9 (en) 2011-01-25 2017-03-15 Viviabiotech, S.L. 1,2,4-oxadiazole derivatives as drugs modulating the glp-1 peptide receptor
EP2867230B1 (en) 2012-07-02 2020-02-12 Monsanto Technology LLC Process for the preparation of 3,5-disubstituted-1,2,4-oxadiazoles
KR102497273B1 (ko) 2014-03-06 2023-02-07 피티씨 테라퓨틱스, 인크. 1,2,4-옥사디아졸 벤조산의 약학 조성물 및 염
CN105461650B (zh) * 2014-09-12 2018-04-13 杭州普晒医药科技有限公司 一种噁二唑化合物的溶剂化物及其制备方法
CN106316885B (zh) * 2015-07-03 2019-02-12 普济生物科技(台州)有限公司 一种3-[5-(2-氟苯基)-1,2,4-噁二唑-3-基]苯甲酸的制备方法
JP2018531975A (ja) 2015-10-30 2018-11-01 ピーティーシー セラピューティクス,インコーポレーテッド てんかんの治療方法
TW201808922A (zh) 2016-06-20 2018-03-16 台灣神隆股份有限公司 製備阿塔魯仁及其中間體的方法
WO2020128816A2 (en) 2018-12-20 2020-06-25 Pfizer Inc. Pharmaceutical compositions and methods comprising a combination of a benzoxazole transthyretin stabilizer and an additional therapeutic agent
EP3952867A4 (en) 2019-04-10 2023-01-11 PTC Therapeutics, Inc. METHODS OF TREATMENT OF NONSENSE MUTATION MEDIATED DUCHENNE MUSCULAR DYSTROPHY IN PEDIATRIC PATIENTS
WO2022112919A1 (en) 2020-11-25 2022-06-02 Pfizer Inc. (aza)benzothiazolyl substituted pyrazole compounds
CN113045510B (zh) * 2021-03-31 2022-05-27 北京大学生命科学华东产业研究院 一种阿塔鲁伦的制备方法
CN114920667B (zh) * 2022-06-30 2024-06-21 湖南大学 一种阿塔鲁伦酯的电化学制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2801509A1 (de) * 1978-01-12 1979-07-19 Schering Ag 1,2,4-oxadiazolderivate, verfahren zur herstellung dieser verbindungen sowie diese enthaltende selektive herbizide mittel
DE3905242A1 (de) * 1989-02-21 1990-08-23 Basf Ag Verfahren zur herstellung von phenyloxdiazolylanilinen
NZ234760A (en) * 1989-08-18 1991-09-25 Sterling Drug Inc Antiviral oxazole compounds and compositions
DE4425794A1 (de) * 1994-07-21 1996-01-25 Basf Ag Nitrofarbstoffe
US6660753B2 (en) * 1999-08-19 2003-12-09 Nps Pharmaceuticals, Inc. Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
JP2005504014A (ja) * 2001-06-08 2005-02-10 サイトビア インコーポレイテッド カスパーゼの活性化因子およびアポトーシスの誘導因子としての置換された3−アリール−5−アリール−[1,2,4]−オキサジアゾール類および類似体、並びにその使用法
MY151199A (en) * 2001-11-02 2014-04-30 Rigel Pharmaceuticals Inc Substituted diphenyl heterocycles useful for treating hcv infection
TW200424183A (en) * 2002-08-09 2004-11-16 Nps Pharma Inc New compounds
GB0303503D0 (en) 2003-02-14 2003-03-19 Novartis Ag Organic compounds
HUE047569T2 (hu) * 2003-04-11 2020-04-28 Ptc Therapeutics Inc 1,2,4-oxadiazol-benzoesav vegyület és nonszensz szupresszióra történõ alkalmazása
WO2004110351A2 (en) * 2003-05-14 2004-12-23 Anadys Pharmaceuticals, Inc. Heterocyclic compounds for treating hepatitis c virus
PT2402002T (pt) 2005-04-08 2018-10-08 Ptc Therapeutics Inc Composições de 1,2,4-oxadiazole oralmente activo para terapia de supressão de mutações nonsense
MX2009002439A (es) * 2006-09-08 2009-03-27 Ptc Therapeutics Inc Procesos para la preparacion de acidos 1,2,4-oxadiazolbenzoicos.

Similar Documents

Publication Publication Date Title
JP2010502715A5 (https=)
RU2009113019A (ru) Способы получения 1,2,4-оксадиазолбензойных кислот
JP2012515142A5 (https=)
JP2009527517A5 (https=)
RU2012154809A (ru) Очистка позаконазола и промежуточных продуктов для синтеза позаконазола
JP2009235096A5 (https=)
JP2018065832A (ja) ベンズイミダゾール誘導体の製造方法
JP2013520495A5 (https=)
JP2018507858A (ja) トピロキソスタット及びその中間体の調製のための方法
CN111278830A (zh) 一种parp抑制剂及其中间体的制备方法
RU2009121819A (ru) Производные моноацетата циклопентендиола
JP2013521224A5 (https=)
KR100881617B1 (ko) 아토바스타틴 제조를 위한 중간체 및 그의 제조방법
JP2011511053A5 (https=)
CN102964307B (zh) 一种达比加群酯有关物质及其制备方法
JP6197868B2 (ja) ピリダジノン化合物の製造方法
JP6459703B2 (ja) シクロヘキサンジカルボン酸モノエステル化合物の製造方法
JP2011523659A5 (https=)
CN102850326B (zh) 一种达比加群酯中间体及其制备方法和应用
JP2013518093A5 (https=)
CN111410607B (zh) 六氢呋喃并呋喃醇衍生物的制备方法、其中间体及其制备方法
JP2011074063A5 (https=)
KR20100034256A (ko) 신규한 1,3-부타다이엔-2-일 메틸 아민 유도체 및 유기 인듐 시약을 이용한 이의 제조방법
JP2010037237A (ja) カルボン酸エステルの製造方法
JP2009528978A (ja) エパルレスタットの主要中間体であるロダニン−3−酢酸の調製方法